Skip to main content
Kangmei Pharmaceutical Co.,Ltd logo

Kangmei Pharmaceutical Co.,Ltd — Investor Relations & Filings

Ticker · 600518 ISIN · CNE0000017M1 LEI · 3003006FRNBUUTVKBB50 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 2,369 across all filing types
Latest filing 2025-01-23 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600518

About Kangmei Pharmaceutical Co.,Ltd

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co.,Ltd. focuses on the research, development, production, and distribution of Traditional Chinese Medicine (TCM). The company manages an integrated industry chain that includes herbal cultivation, standardized processing of decoction pieces, and the manufacturing of patent medicines. Its offerings extend to health supplements, medical devices, and functional foods. A key component of its operations is the management of large-scale TCM trading centers and logistics hubs designed to standardize the trade of medicinal materials. Through its "Internet + Healthcare" initiatives, the company provides digital health management and pharmaceutical supply chain services, catering to medical institutions, retail pharmacies, and individual consumers.

Recent filings

Filing Released Lang Actions
独立董事候选人声明与承诺（赖小平）
Board/Management Information Classification · 95% confidence The document is a declaration and commitment statement by an independent director candidate, detailing qualifications, compliance with laws and regulations, and independence criteria. It is not a financial report, earnings release, or any form of meeting material. It does not announce voting results or changes in management but is related to governance and compliance with regulatory requirements for board members. This fits best under Board/Management Information (MANG) as it concerns nomination and qualifications of a board member candidate.
2025-01-23 Chinese
康美药业关于董事会、监事会换届选举的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and nomination of the company's board of directors and supervisory board members. It details the candidates, their qualifications, and the election process for the new board and supervisory members. There is no financial data, no mention of financial results, nor is it a report or presentation. It is clearly an announcement about changes in the company's board and management structure. Therefore, it fits the category of Board/Management Information (MANG). The document length is about 4500 characters, which is consistent with an announcement rather than a full report.
2025-01-23 Chinese
康美药业关于推选职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement from the company's board regarding the nomination of an employee representative supervisor to the supervisory board. It includes a statement of responsibility from the board and a brief resume of the nominated individual. There is no financial data, no mention of financial results, no regulatory filings, or other report types. The content is about board/management information, specifically about the composition of the supervisory board. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a report or announcement of a report.
2025-01-23 Chinese
康美药业关于召开2025年第一次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2025 first extraordinary general meeting (临时股东大会) of 康美药业股份有限公司. It includes information about the meeting date, voting methods, agenda items (mainly election of board members and supervisors), voting instructions, attendance, and proxy forms. There is no financial data, earnings information, or report content. The document is clearly an announcement and notice related to a shareholders meeting, specifically an Extraordinary General Meeting (EGM). It is not a report itself but a meeting notice and related procedural information. According to the filing definitions, this fits best under AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting or similar shareholder meetings. Although this is an extraordinary meeting, the category AGM-R is the closest match for shareholder meeting notices and materials. The document length is about 4806 characters, which is consistent with a detailed meeting notice rather than a full report or voting results announcement. Therefore, the classification is AGM-R with high confidence.
2025-01-23 Chinese
康美药业第九届董事会2025年度第一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of resolutions passed at the company's board of directors meeting, specifically the first extraordinary meeting of the ninth board in 2025. It details nominations for the next board of directors and the scheduling of a shareholders' meeting. There are no financial statements, audit information, or detailed financial data presented. The document is a formal announcement of board and management changes and related meeting decisions. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report or presentation but an official announcement of board decisions.
2025-01-23 Chinese
康美药业第九届监事会2025年度第一次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Kangmei Pharmaceutical Co., Ltd. regarding the nomination of candidates for the next Supervisory Board term. It includes details about the meeting, voting results, and references to related announcements on the stock exchange website. There is no financial data, audit information, or report content. It is an announcement about board/management changes, specifically related to the Supervisory Board nominations and election process. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2025-01-23 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.